rs2073618
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000297350.9(TNFRSF11B):āc.9C>Gā(p.Asn3Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.495 in 1,590,136 control chromosomes in the GnomAD database, including 203,467 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N3H) has been classified as Likely benign.
Frequency
Consequence
ENST00000297350.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF11B | NM_002546.4 | c.9C>G | p.Asn3Lys | missense_variant | 1/5 | ENST00000297350.9 | NP_002537.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFRSF11B | ENST00000297350.9 | c.9C>G | p.Asn3Lys | missense_variant | 1/5 | 1 | NM_002546.4 | ENSP00000297350 | P1 | |
TNFRSF11B | ENST00000517352.1 | c.9C>G | p.Asn3Lys | missense_variant, NMD_transcript_variant | 1/5 | 1 | ENSP00000427924 |
Frequencies
GnomAD3 genomes AF: 0.597 AC: 90803AN: 152012Hom.: 29521 Cov.: 33
GnomAD3 exomes AF: 0.522 AC: 108753AN: 208262Hom.: 29941 AF XY: 0.518 AC XY: 58179AN XY: 112388
GnomAD4 exome AF: 0.484 AC: 695774AN: 1438006Hom.: 173892 Cov.: 47 AF XY: 0.486 AC XY: 346119AN XY: 712718
GnomAD4 genome AF: 0.598 AC: 90910AN: 152130Hom.: 29575 Cov.: 33 AF XY: 0.600 AC XY: 44617AN XY: 74370
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | This variant is associated with the following publications: (PMID: 28728263, 25679449, 12096838, 18938269, 20205168, 15312251, 19131500, 19128145, 22965192, 19705167) - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 28, 2017 | - - |
Hyperphosphatasemia with bone disease Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at